GCTM-2 antigen antibody
Gp2 antibody
Gp200 antibody
MGC138240 antibody
PC antibody
PCLP antibody
PCLP-1 antibody
PCLP1 antibody
Pcx antibody
Podocalyxin antibody
Podocalyxin like antibody
Podocalyxin like protein antibody
Podocalyxin-like protein 1 antibody
Podxl antibody
PODXL_HUMAN antibody
Product description
Podocalyxin, a sialoglycoprotein, is thought to be the major constituent of the glycocalyx of podocytes. It is a member of the CD34 family of transmembrane sialomucins. It is involved in the regulation of both adhesion and cell morphology and cancer progression. It functions as an anti-adhesive molecule that maintains an open filtration pathway between neighboring foot processes in the podocyte by charge repulsion. Podocalyxin acts as a pro-adhesive molecule, enhancing the adherence of cells to immobilized ligands, increasing the rate of migration and cell-cell contacts in an integrin-dependent manner. Sialylated, O-glycosylated glycoforms of podocalyxin expressed by colon carcinoma cells possess L-selectin and E-selectin binding activity, and may be pivotal to the metastatic spread of colon carcinoma cells
Immunogen
recombinant protein
Key Feature
Clonality
Monoclonal
Isotype
IgG1
Host Species
Mouse
Tested Applications
WB
WB 1:2,000-1:5,000:
Species Reactivity
Human
Concentration
2mg/ml
Target Information
Alternative Names
GCTM-2 antigen antibody
Gp2 antibody
Gp200 antibody
MGC138240 antibody
PC antibody
PCLP antibody
PCLP-1 antibody
PCLP1 antibody
Pcx antibody
Podocalyxin antibody
Podocalyxin like antibody
Podocalyxin like protein antibody
Podocalyxin-like protein 1 antibody
Podxl antibody
PODXL_HUMAN antibody